BACKGROUND: Identification of biomarkers associated with survival in patients with cancer is important for elucidating the underlying mechanisms of cancer progression and identifying possible interventions to reduce cancer morbidity and mortality. METHODS: Using stored patient plasma samples from a multiethnic population-based case-control study of invasive colorectal cancer, we measured posttreatment blood levels of C-reactive protein (CRP) and lipid-soluble micronutrients. Patients (n = 368) were followed after phlebotomy (mean of 8 years), during which time 47% died (25% colorectal cancer specific). HRs were estimated by Cox proportional hazards regression with adjustment for stage, age at diagnosis, ethnicity, sex, smoking status, and month of blood draw. RESULTS: A positive association with overall risk of death was observed for CRP [HR for highest vs. lowest quintile: 1.80; 95% confidence interval (CI), 1.07-3.04; Ptrend = 0.01], whereas inverse associations were generally observed for retinol and carotenoids (HRs for overall risk of death for the highest quintile ranging from 0.5-0.8); these associations were significant for retinol (Ptrend = 0.0002), α-carotene (Ptrend = 0.02), and total carotenoids (Ptrend = 0.02) and were generally consistent across subgroups (sex, ethnicity, cancer anatomical subtype, and stage). HRs for retinol and carotenoids were attenuated somewhat after adjustment for CRP. Similar trends for CRP were observed for colorectal cancer-specific deaths (HR for highest vs. lowest tertile: 2.06; 95% CI, 1.18-3.61; Ptrend = 0.01) as for deaths from all other causes (Pheterogeneity = 0.78). CONCLUSIONS: These observations are consistent with a direct relationship between circulating CRP and overall survival among patients with colorectal cancer. IMPACT: These results, if reproduced, suggest that reduction of inflammation should be explored as a potential complementary treatment strategy.
BACKGROUND: Identification of biomarkers associated with survival in patients with cancer is important for elucidating the underlying mechanisms of cancer progression and identifying possible interventions to reduce cancer morbidity and mortality. METHODS: Using stored patient plasma samples from a multiethnic population-based case-control study of invasive colorectal cancer, we measured posttreatment blood levels of C-reactive protein (CRP) and lipid-soluble micronutrients. Patients (n = 368) were followed after phlebotomy (mean of 8 years), during which time 47% died (25% colorectal cancer specific). HRs were estimated by Cox proportional hazards regression with adjustment for stage, age at diagnosis, ethnicity, sex, smoking status, and month of blood draw. RESULTS: A positive association with overall risk of death was observed for CRP [HR for highest vs. lowest quintile: 1.80; 95% confidence interval (CI), 1.07-3.04; Ptrend = 0.01], whereas inverse associations were generally observed for retinol and carotenoids (HRs for overall risk of death for the highest quintile ranging from 0.5-0.8); these associations were significant for retinol (Ptrend = 0.0002), α-carotene (Ptrend = 0.02), and total carotenoids (Ptrend = 0.02) and were generally consistent across subgroups (sex, ethnicity, cancer anatomical subtype, and stage). HRs for retinol and carotenoids were attenuated somewhat after adjustment for CRP. Similar trends for CRP were observed for colorectal cancer-specific deaths (HR for highest vs. lowest tertile: 2.06; 95% CI, 1.18-3.61; Ptrend = 0.01) as for deaths from all other causes (Pheterogeneity = 0.78). CONCLUSIONS: These observations are consistent with a direct relationship between circulating CRP and overall survival among patients with colorectal cancer. IMPACT: These results, if reproduced, suggest that reduction of inflammation should be explored as a potential complementary treatment strategy.
Authors: Nikolaos I Nikiteas; Nikolaos Tzanakis; Maria Gazouli; George Rallis; Kessaris Daniilidis; George Theodoropoulos; Alkiviadis Kostakis; George Peros Journal: World J Gastroenterol Date: 2005-03-21 Impact factor: 5.742
Authors: Gertraud Maskarinec; Brook E Harmon; Melissa A Little; Nicholas J Ollberding; Laurence N Kolonel; Brian E Henderson; Loic Le Marchand; Lynne R Wilkens Journal: Cancer Causes Control Date: 2015-09-10 Impact factor: 2.506
Authors: Yin Cao; Jeffrey A Meyerhardt; Andrew T Chan; Kana Wu; Charles S Fuchs; Edward L Giovannucci Journal: Cancer Causes Control Date: 2015-08-21 Impact factor: 2.506
Authors: Nitin Shivappa; Cindy K Blair; Anna E Prizment; David R Jacobs; Susan E Steck; James R Hébert Journal: Eur J Nutr Date: 2015-07-01 Impact factor: 5.614
Authors: Jiali Zheng; Fred K Tabung; Jiajia Zhang; Angela D Liese; Nitin Shivappa; Judith K Ockene; Bette Caan; Candyce H Kroenke; James R Hébert; Susan E Steck Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-01-22 Impact factor: 4.254
Authors: Brook E Harmon; Michael D Wirth; Carol J Boushey; Lynne R Wilkens; Emma Draluck; Nitin Shivappa; Susan E Steck; Lorne Hofseth; Christopher A Haiman; Loic Le Marchand; James R Hébert Journal: J Nutr Date: 2017-02-08 Impact factor: 4.798
Authors: Jiali Zheng; Fred K Tabung; Jiajia Zhang; E Angela Murphy; Nitin Shivappa; Judith K Ockene; Bette Caan; Candyce H Kroenke; James R Hébert; Susan E Steck Journal: Eur J Nutr Date: 2019-04-06 Impact factor: 5.614
Authors: Simone Jacobs; Brook E Harmon; Nicholas J Ollberding; Lynne R Wilkens; Kristine R Monroe; Laurence N Kolonel; Loic Le Marchand; Carol J Boushey; Gertraud Maskarinec Journal: J Nutr Date: 2016-08-10 Impact factor: 4.798